LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive Account

Home News ArchiveBayer's Asundexian Approved In China For Stroke Risk Reduction

Live News GEOPOLITICS FLASH L impact Oct 26, 2026, 08:16 AM UTC

Bayer's Asundexian Approved In China For Stroke Risk Reduction

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Nurse Killed, Another Worker Wounded in Congo Over Ebola Accusations A nurse was killed and another worker wounded in the Democratic Republic of the Congo after they were accused of spreading Ebola. L impact | GEOPOLITICS | Oct 26, 2026, 10:33 AM UTC China United Network President Jian Qin resigns for job transition L impact | GEOPOLITICS | Oct 26, 2026, 10:05 AM UTC Russia says it arrested two Ukrainian agents planning drone attack Russia says two agents for Ukraine were arrested while preparing a drone attack. L impact | GEOPOLITICS | Oct 26, 2026, 09:53 AM UTC Kremlin expects new Serbian leaders to collaborate with Russia: ifx H impact | GEOPOLITICS | Oct 26, 2026, 09:52 AM UTC Kremlin Says Agreement To Resume 3-Way Talks With Ukraine And US Does Not Place Any Restrictions On Moscow Or Kyiv When It Comes To Continuing Military Action H impact | GEOPOLITICS | Oct 26, 2026, 09:51 AM UTC Russia Says It Foiled Ukrainian Drone Attack on Moscow Air Defenses Russia said it thwarted a Ukrainian drone attack targeting Moscow's air defenses. M impact | GEOPOLITICS | Oct 26, 2026, 09:39 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.